跳至主要内容
临床试验/NCT00453557
NCT00453557已完成4 期

Mechanism of Growth Hormone Effects on Adipose Tissue

Pennington Biomedical Research Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 1999年4月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
2
主要终点
energy expenditure at baseline, after 6 months of treatment and at the end of the followup period

研究概览

简要总结

Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.

详细描述

Growth hormone (GH) replacement in GH deficient adults results in an improvement in metabolic status, an increase in lean body mass and a reduction in visceral adiposity. GH might also decrease visceral adiposity in obese adults that are not GH deficient.

The objective of the study is to determine the effects of GH on the metabolic syndrome and visceral adiposity in men with low blood levels of IGF-1 and the durability of these effects after stopping GH therapy. We will use a double blind, placebo controlled 6 month intervention trial followed by a blinded follow-up period of 6 months. Thirty non-diabetic middle aged men with central adiposity (BMI > 27 kg/m2, waist circumference > 102 cm) will participate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male, aged 40-70
  • Central obesity defined as waist circumference greater than 102 cm and BMI > 27 and < 35 kg/m2
  • No weight loss in last 12 months
  • Total IGF-1 level < 241 ng/ml (~25th percentile for the assay)
  • Body habitus which permitted accurate CT scan acquisition and analysis.

排除标准

  • Significant neurologic, metabolic, endocrine, cardiac, respiratory or gastrointestinal disease
  • Known coronary heart disease
  • Exercised more than 3 hours per week
  • Unwilling or unable to abstain from alcohol for 72 hours prior to the measurements of energy expenditure and fasting blood work

结局指标

主要结局

energy expenditure at baseline, after 6 months of treatment and at the end of the followup period

body composition at baseline, after 6 months of treatment and at the end of the followup period

次要结局

  • gene expression in adipose tissue at baseline and after 6 months of treatment

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frank Greenway

Clinical Medical Doctor

Pennington Biomedical Research Center

研究点 (2)

Loading locations...

相似试验